Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01EYM
|
|||
| Former ID |
DIB000251
|
|||
| Drug Name |
BB-2275
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Terminated | [1] | |
| Company |
Vernalis plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TNF receptor (TNFR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003251) | |||
| REF 2 | Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA sy... J Clin Invest. 1996 Jun 15;97(12):2833-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.